HSDT vs. AEMD, LYRA, BLAC, CHEK, LUCY, NUWE, AMIX, GCTK, HSCS, and QNRX
Should you be buying Helius Medical Technologies stock or one of its competitors? The main competitors of Helius Medical Technologies include Aethlon Medical (AEMD), Lyra Therapeutics (LYRA), Bellevue Life Sciences Acquisition (BLAC), Check-Cap (CHEK), Innovative Eyewear (LUCY), Nuwellis (NUWE), Autonomix Medical (AMIX), GlucoTrack (GCTK), Heart Test Laboratories (HSCS), and Quoin Pharmaceuticals (QNRX). These companies are all part of the "medical equipment" industry.
Helius Medical Technologies vs.
Aethlon Medical (NASDAQ:AEMD) and Helius Medical Technologies (NASDAQ:HSDT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, community ranking, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.
Aethlon Medical has a net margin of 0.00% compared to Helius Medical Technologies' net margin of -1,764.74%. Aethlon Medical's return on equity of -153.96% beat Helius Medical Technologies' return on equity.
Aethlon Medical currently has a consensus target price of $7.00, suggesting a potential upside of 1,654.39%. Given Aethlon Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe Aethlon Medical is more favorable than Helius Medical Technologies.
2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 18.6% of Helius Medical Technologies shares are held by institutional investors. 1.1% of Aethlon Medical shares are held by company insiders. Comparatively, 17.9% of Helius Medical Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
In the previous week, Helius Medical Technologies had 2 more articles in the media than Aethlon Medical. MarketBeat recorded 2 mentions for Helius Medical Technologies and 0 mentions for Aethlon Medical. Helius Medical Technologies' average media sentiment score of 0.66 beat Aethlon Medical's score of 0.00 indicating that Helius Medical Technologies is being referred to more favorably in the news media.
Helius Medical Technologies has lower revenue, but higher earnings than Aethlon Medical. Aethlon Medical is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks.
Aethlon Medical has a beta of 1.93, indicating that its share price is 93% more volatile than the S&P 500. Comparatively, Helius Medical Technologies has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500.
Aethlon Medical received 201 more outperform votes than Helius Medical Technologies when rated by MarketBeat users. However, 55.56% of users gave Helius Medical Technologies an outperform vote while only 50.11% of users gave Aethlon Medical an outperform vote.
Summary
Aethlon Medical beats Helius Medical Technologies on 12 of the 18 factors compared between the two stocks.
Get Helius Medical Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Helius Medical Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:HSDT) was last updated on 5/22/2025 by MarketBeat.com Staff